Pune, Dec. 02, 2021 (GLOBE NEWSWIRE) -- According to the latest trending report published by growth plus reports Titled “Autoimmune Disease Diagnosis Market – Global Outlook & Forecast 2021-2031” The Global Autoimmune Disease Diagnosis Market is expected to clock US$ ~9.79 billion by 2031 owing to the rising incidence of autoimmune diseases and growing public awareness about autoimmune diseases and their diagnosis.
The rising prevalence of autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, lupus, Crohn’s disease, and multiple sclerosis, among others is one of the key factors driving the growth of the autoimmune disease diagnosis market.
Moreover, the increasing geriatric population, rise in healthcare expenditure, and the growing number of product launches are some of the other factors fueling the autoimmune disease diagnostics market growth.
Furthermore, the growing awareness about autoimmune diseases and the need for diagnosis are boosting the market growth.
The global autoimmune disease diagnosis market has been analyzed from four perspectives: Product, Type, Test Type, and Region.
Request a Sample Copy of the Research Report: https://growthplusreports.com/request-sample-report/?autoimmune-disease-diagnosis-market
Excerpts from ‘By Type Segmentation’
Based on type, the market has been segmented into localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics. Localized autoimmune disease diagnostics segment is further bifurcated into type 1 diabetes, multiple sclerosis, idiopathic thrombocytopenic purpura, Hashimoto's thyroiditis, and others (such as Addison’s disease, grave’s disease, myasthenia gravis, etc.). Similarly, systemic autoimmune disease diagnostics is categorized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others (scleroderma, sjögren’s syndrome, antiphospholipid antibody syndromes, etc.). Localized autoimmune disease diagnostics dominated the autoimmune disease diagnosis market in terms of revenue in 2020. Factors driving the growth of this segment include the rising incidence of localized autoimmune diseases such as type 1 diabetes, and multiple sclerosis; and growing patient awareness for getting tested for these diseases.
Excerpts from ‘By Region Segmentation’
Regionally, the global autoimmune disease diagnosis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the market for autoimmune disease diagnosis holding the largest market share in 2020. The rising incidence of autoimmune diseases and conduct of greater number of tests are fueling the demand for diagnostic products for autoimmune diseases in the region. According to the National Institutes of Health, around 23.5 million Americans i.e., more than 7% of the population suffer from an autoimmune disease. Moreover, factors such as greater awareness regarding the diseases and the available tests; and high healthcare expenditure are anticipated to boost the market growth during the projected period.
Get your customized report right now: https://growthplusreports.com/ask-for-customization/?autoimmune-disease-diagnosis-market
Excerpts from ‘Competitive Landscape’
Some of the prominent players operating in the global autoimmune disease diagnosis market include
Thermo Fisher Scientific Inc
Siemens Healthcare Private Limited
Trinity Biotech Plc
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
Beckman Coulter, Inc
Euroimmun Medizinische Labordiagnostika AG (a PerkinElmer company)
2021 to 2031
Forecast Period 2021 to 2031 CAGR
2031 Market Value
USD 9.79 billion
2018 and 2019
Number of pages
100 - 120
Product, Type, Test type,
Table of contents:
Timeline Under Consideration
Historical Years – 2018 & 2019
Base Year – 2020
Forecasted Years – 2021 to 2031
Currency Used in the Report
Data Collection Methodology
Market Estimation Approach
Market Forecasting Model
Limitations and Assumptions
Current Market Trend (COVID-19 Perspective)
Key Players & Their Competitive Positioning (2020)
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Distributor Landscape Assessment
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players
Check for a discount now at: https://growthplusreports.com/check-discount/?autoimmune-disease-diagnosis-market
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
CONTACT: Manan Sethi Director, Market Insights Email: email@example.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/ Follow Us: LinkedIn | Twitter